The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke
ConditionStroke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMarmara University
About this trial
Objective The aim of this study is to investigate the effects of an augmented reality-based mirror therapy system (MirrARm), developed using sensor-based tracking and visual feedback principles, on upper extremity motor recovery and functional activity levels in patients with stroke.
Research Questions
This study seeks to address the following questions:
Does the MirrARm system improve upper extremity motor recovery and functional activity levels in patients with stroke?
Are the effects of the MirrARm system on upper extremity motor recovery and functional activity levels greater than those of conventional mirror therapy in patients with stroke?
Study Design and Comparison The MirrARm system will be compared with conventional mirror therapy to evaluate its effectiveness in patients with stroke.
Participants and Procedures Participants will take part in a treatment program administered three days per week for a total duration of eight weeks. Outcome measures will be assessed at baseline (Week 0), at mid-intervention (Week 4), and at the end of the intervention period (Week 8).
Eligibility criteria
Qualifiers
First-ever unilateral stroke diagnosed by a specialist physician,
Presence of post-stroke hemiplegia,
Age ≥ 18 years,
Time since stroke between 3 and 12 months,
Disqualifiers
Inability to sit independently in a supported chair,
Insufficient communication ability due to aphasia,
Presence of structural and/or acquired impairments limiting active movement of the unaffected upper limb,
Presence of visual or visual-perceptual impairments,
Trial design
Treatments tested in this trial
- Augmented Reality-Based Mirror Therapy
- Conventional Mirror Therapy
- Conventional Physiotherapy Treatment
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Marmara University
Lead sponsor
Marmara University Scientific Research Projects Unit
Collaborator
Source ClinicalTrials.gov